GenAssist Therapeutics
GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the field of DMD treatment.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed GenAssist Therapeutics Information
Geographic Data
Address:
City: Suzhou
State: Jiangsu
Zip:
Country: China
Financial Info
Stage:
seed
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the field of DMD treatment. Founded in 2020, GenAssist was founded by outstanding scientists and industry experts in July 2020. They are committed to the development of gene editing drugs for a variety of genetic diseases.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Series A | 3 | - |
Sequoia Capital China Baidu Ventures AstraZeneca Sequoia Capital China Baidu Ventures AstraZeneca |
12/2020 | Seed Round | 1 | - |
Redhill Capital Redhill Capital |
12/2020 | Seed Round | 1 | - |
Redhill Capital Redhill Capital |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
